Another study indicated the possible action of SGLT-2 inhibitor on NAFLD is attributed to the regulation of endoplasmic reticulum (ER), oxidative stress, and autophagy. Here, SLC5A2 is linked to metabolic dysfunction-associated steatotic liver disease.